Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q55662078 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000200.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q55662078 | ||
024 | ‡a 0000-0003-0657-1907 ‡2 orcid | ||
024 | ‡a 7201882408 ‡2 scopus | ||
035 | ‡a (OCoLC)Q55662078 | ||
100 | 0 | ‡a Ana Sofia Carvalho ‡9 ast ‡9 es ‡9 sl | |
375 | ‡a 2 ‡2 iso5218 | ||
400 | 0 | ‡a Ana Sofia Carvalho ‡c researcher (ORCID 0000-0003-0657-1907) ‡9 en | |
400 | 0 | ‡a Ana Sofia Carvalho ‡c onderzoeker ‡9 nl | |
670 | ‡a Author's Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. | ||
670 | ‡a Author's Bottom up proteomics data analysis strategies to explore protein modifications and genomic variants. | ||
670 | ‡a Author's Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer | ||
670 | ‡a Author's Bronchoalveolar Lavage: Quantitative Mass Spectrometry-Based Proteomics Analysis in Lung Diseases | ||
670 | ‡a Author's Conformational states of HRPA1 induced by thermal unfolding: effect of low molecular weight solutes. | ||
670 | ‡a Author's Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. | ||
670 | ‡a Author's Discussion on common data analysis strategies used in MS-based proteomics. | ||
670 | ‡a Author's Evening and morning alterations in Obstructive Sleep Apnea red blood cell proteome | ||
670 | ‡a Author's Evening and morning peroxiredoxin-2 redox/oligomeric state changes in obstructive sleep apnea red blood cells: Correlation with polysomnographic and metabolic parameters | ||
670 | ‡a Author's Extra-cellular vesicles carry proteome of cancer hallmarks | ||
670 | ‡a Author's Folding Status Is Determinant over Traffic-Competence in Defining CFTR Interactors in the Endoplasmic Reticulum. | ||
670 | ‡a Author's Formation of a misfolded conformation during refolding of HRPA1 in the presence of calcium. | ||
670 | ‡a Author's Global mass spectrometry and transcriptomics array based drug profiling provides novel insight into glucosamine induced endoplasmic reticulum stress | ||
670 | ‡a Author's Global MS-Based Proteomics Drug Profiling. | ||
670 | ‡a Author's Helicobacter pylori cagpathogenicity island-positive strains induce syndecan-4 expression in gastric epithelial cells | ||
670 | ‡a Author's Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. | ||
670 | ‡a Author's IgG+ Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer | ||
670 | ‡a Author's Infection-associated FUT2 | ||
670 | ‡a Author's Infection-associated FUT2 (Fucosyltransferase 2) genetic variation and impact on functionality assessed by in vivo studies. | ||
670 | ‡a Author's Influence of Aldehyde Dehydrogenase Inhibition on Stemness of Endometrial Cancer Stem Cells | ||
670 | ‡a Author's Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function | ||
670 | ‡a Author's Is the Proteome of Bronchoalveolar Lavage Extracellular Vesicles a Marker of Advanced Lung Cancer? | ||
670 | ‡a Author's LAMP2A regulates the loading of proteins into exosomes | ||
670 | ‡a Author's Methods and algorithms for quantitative proteomics by mass spectrometry | ||
670 | ‡a Author's Methods and algorithms for relative quantitative proteomics by mass spectrometry | ||
670 | ‡a Author's MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. | ||
670 | ‡a Author's New insights into functional regulation in MS-based drug profiling. | ||
670 | ‡a Author's New insights into host-parasite ubiquitin proteome dynamics in P. falciparum infected red blood cells using a TUBEs-MS approach | ||
670 | ‡a Author's Overview of proteomics studies in obstructive sleep apnea | ||
670 | ‡a Author's Photophysics and photochemistry of horseradish peroxidase A2 upon ultraviolet illumination. | ||
670 | ‡a Author's Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma | ||
670 | ‡a Author's Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation | ||
670 | ‡a Author's Proteomic Profiling of Plasma- and Gut-Derived Extracellular Vesicles in Obesity | ||
670 | ‡a Author's Quantitative proteome analysis of an antibiotic resistant Escherichia coli exposed to tetracycline reveals multiple affected metabolic and peptidoglycan processes | ||
670 | ‡a Author's Red Blood Cells in Clinical Proteomics. | ||
670 | ‡a Author's Review and Literature Mining on Proteostasis Factors and Cancer. | ||
670 | ‡a Author's SIR: Deterministic protein inference from peptides assigned to MS data. | ||
670 | ‡a Author's WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1 | ||
909 | ‡a (scopus) 7201882408 ‡9 1 | ||
909 | ‡a (orcid) 0000000306571907 ‡9 1 | ||
919 | ‡a lamp2aregulatestheloadingofproteinsintoexosomes ‡A LAMP2A regulates the loading of proteins into exosomes ‡9 1 | ||
919 | ‡a newinsightsintofunctionalregulationinmsbaseddrugprofiling ‡A New insights into functional regulation in MS-based drug profiling. ‡9 1 | ||
919 | ‡a newinsightsintohostparasiteubiquitinproteomedynamicsinpfalciparuminfectedredbloodcellsusingatubesmsapproach ‡A New insights into host-parasite ubiquitin proteome dynamics in P. falciparum infected red blood cells using a TUBEs-MS approach ‡9 1 | ||
919 | ‡a overviewofproteomicsstudiesinobstructivesleepapnea ‡A Overview of proteomics studies in obstructive sleep apnea ‡9 1 | ||
919 | ‡a istheproteomeofbronchoalveolarlavageextracellularvesiclesamarkerofadvancedlungcancer ‡A Is the Proteome of Bronchoalveolar Lavage Extracellular Vesicles a Marker of Advanced Lung Cancer? ‡9 1 | ||
919 | ‡a interplaybetweensumoylationandneddylationregulatesrpl11localizationandfunction ‡A Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function ‡9 1 | ||
919 | ‡a influenceofaldehydedehydrogenaseinhibitiononstemnessofendometrialcancerstemcells ‡A Influence of Aldehyde Dehydrogenase Inhibition on Stemness of Endometrial Cancer Stem Cells ‡9 1 | ||
919 | ‡a infectionassociatedfut2fucosyltransferase2geneticvariationandimpactonfunctionalityassessedbyinvivostudies ‡A Infection-associated FUT2 (Fucosyltransferase 2) genetic variation and impact on functionality assessed by in vivo studies. ‡9 1 | ||
919 | ‡a infectionassociatedfut2 ‡A Infection-associated FUT2 ‡9 1 | ||
919 | ‡a igg+extracellularvesiclesmeasuretherapeuticresponseinadvancedpancreaticcancer ‡A IgG+ Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer ‡9 1 | ||
919 | ‡a photophysicsandphotochemistryofhorseradishperoxidasea2uponultravioletillumination ‡A Photophysics and photochemistry of horseradish peroxidase A2 upon ultraviolet illumination. ‡9 1 | ||
919 | ‡a profilingoflungmicrobiotadisclosesdifferencesinadenocarcinomaandsquamouscellcarcinoma ‡A Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma ‡9 1 | ||
919 | ‡a proteomicinteractionprofilingrevealskifc1asafactorinvolvedinearlytargetingoff508delcftrtodegradation ‡A Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation ‡9 1 | ||
919 | ‡a proteomicprofilingofplasmaandgutderivedextracellularvesiclesinobesity ‡A Proteomic Profiling of Plasma- and Gut-Derived Extracellular Vesicles in Obesity ‡9 1 | ||
919 | ‡a quantitativeproteomeanalysisofanantibioticresistantescherichiacoliexposedtotetracyclinerevealsmultipleaffectedmetabolicandpeptidoglycanprocesses ‡A Quantitative proteome analysis of an antibiotic resistant Escherichia coli exposed to tetracycline reveals multiple affected metabolic and peptidoglycan processes ‡9 1 | ||
919 | ‡a redbloodcellsinclinicalproteomics ‡A Red Blood Cells in Clinical Proteomics. ‡9 1 | ||
919 | ‡a reviewandliteratureminingonproteostasisfactorsandcancer ‡A Review and Literature Mining on Proteostasis Factors and Cancer. ‡9 1 | ||
919 | ‡a sirdeterministicproteininferencefrompeptidesassignedtomsdata ‡A SIR: Deterministic protein inference from peptides assigned to MS data. ‡9 1 | ||
919 | ‡a wnk1phosphorylationsitesintbc1d1andtbc1d4modulatecellsurfaceexpressionofglut1 ‡A WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1 ‡9 1 | ||
919 | ‡a identificationofnewcancerbiomarkersbasedonaberrantmucinglycoformsbyinsituproximityligation ‡A Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. ‡9 1 | ||
919 | ‡a helicobacterpyloricagpathogenicityislandpositivestrainsinducesyndecan4expressioningastricepithelialcells ‡A Helicobacter pylori cagpathogenicity island-positive strains induce syndecan-4 expression in gastric epithelial cells ‡9 1 | ||
919 | ‡a globalmsbasedproteomicsdrugprofiling ‡A Global MS-Based Proteomics Drug Profiling. ‡9 1 | ||
919 | ‡a globalmassspectrometryandtranscriptomicsarraybaseddrugprofilingprovidesnovelinsightintoglucosamineinducedendoplasmicreticulumstress ‡A Global mass spectrometry and transcriptomics array based drug profiling provides novel insight into glucosamine induced endoplasmic reticulum stress ‡9 1 | ||
919 | ‡a formationofamisfoldedconformationduringrefoldingofhrpa1inthepresenceofcalcium ‡A Formation of a misfolded conformation during refolding of HRPA1 in the presence of calcium. ‡9 1 | ||
919 | ‡a foldingstatusisdeterminantovertrafficcompetenceindefiningcftrinteractorsintheendoplasmicreticulum ‡A Folding Status Is Determinant over Traffic-Competence in Defining CFTR Interactors in the Endoplasmic Reticulum. ‡9 1 | ||
919 | ‡a extracellularvesiclescarryproteomeofcancerhallmarks ‡A Extra-cellular vesicles carry proteome of cancer hallmarks ‡9 1 | ||
919 | ‡a eveningandmorningperoxiredoxin2redoxoligomericstatechangesinobstructivesleepapnearedbloodcellscorrelationwithpolysomnographicandmetabolicparameters ‡A Evening and morning peroxiredoxin-2 redox/oligomeric state changes in obstructive sleep apnea red blood cells: Correlation with polysomnographic and metabolic parameters ‡9 1 | ||
919 | ‡a eveningandmorningalterationsinobstructivesleepapnearedbloodcellproteome ‡A Evening and morning alterations in Obstructive Sleep Apnea red blood cell proteome ‡9 1 | ||
919 | ‡a discussiononcommondataanalysisstrategiesusedinmsbasedproteomics ‡A Discussion on common data analysis strategies used in MS-based proteomics. ‡9 1 | ||
919 | ‡a differentialexpressionofalpha23sialyltransferasesandalpha134fucosyltransferasesregulatesthelevelsofsialyllewisaandsialyllewis10ingastrointestinalcarcinomacells ‡A Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. ‡9 1 | ||
919 | ‡a conformationalstatesofhrpa1inducedbythermalunfoldingeffectoflowmolecularweightsolutes ‡A Conformational states of HRPA1 induced by thermal unfolding: effect of low molecular weight solutes. ‡9 1 | ||
919 | ‡a bronchoalveolarlavagequantitativemassspectrometrybasedproteomicsanalysisinlungdiseases ‡A Bronchoalveolar Lavage: Quantitative Mass Spectrometry-Based Proteomics Analysis in Lung Diseases ‡9 1 | ||
919 | ‡a bronchoalveolarlavageproteomicsinpatientswithsuspectedlungcancer ‡A Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer ‡9 1 | ||
919 | ‡a bottomupproteomicsdataanalysisstrategiestoexploreproteinmodificationsandgenomicvariants ‡A Bottom up proteomics data analysis strategies to explore protein modifications and genomic variants. ‡9 1 | ||
919 | ‡a biologicalsignificanceofcancerassociatedsialyltnantigenmodulationofmalignantphenotypeingastriccarcinomacells ‡A Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. ‡9 1 | ||
919 | ‡a muc2mucinisamajorcarrierofthecancerassociatedsialyltnantigeninintestinalmetaplasiaandgastriccarcinomas ‡A MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. ‡9 1 | ||
919 | ‡a methodsandalgorithmsforrelativequantitativeproteomicsbymassspectrometry ‡A Methods and algorithms for relative quantitative proteomics by mass spectrometry ‡9 1 | ||
919 | ‡a methodsandalgorithmsforquantitativeproteomicsbymassspectrometry ‡A Methods and algorithms for quantitative proteomics by mass spectrometry ‡9 1 | ||
946 | ‡a a ‡9 1 | ||
996 | ‡2 SUDOC|17944347X | ||
996 | ‡2 ISNI|0000000066586252 | ||
996 | ‡2 NUKAT|n 2019015505 | ||
996 | ‡2 DNB|1089390238 | ||
996 | ‡2 ISNI|000000006939247X | ||
996 | ‡2 BIBSYS|1670 | ||
996 | ‡2 SUDOC|137079745 | ||
996 | ‡2 BLBNB|001508421 | ||
996 | ‡2 PTBNP|1425219 | ||
996 | ‡2 ISNI|0000000070109440 | ||
996 | ‡2 ISNI|0000000072462483 | ||
996 | ‡2 ISNI|000000006950016X | ||
996 | ‡2 NUKAT|n 2004070693 | ||
996 | ‡2 BLBNB|001452091 | ||
996 | ‡2 LC|n 2005062922 | ||
996 | ‡2 LC|n 82137627 | ||
996 | ‡2 ISNI|0000000070504619 | ||
996 | ‡2 PTBNP|1514592 | ||
996 | ‡2 PTBNP|1860313 | ||
996 | ‡2 PTBNP|1187207 | ||
996 | ‡2 RERO|A025814878 | ||
996 | ‡2 PTBNP|36651 | ||
996 | ‡2 LC|no2022142146 | ||
996 | ‡2 ISNI|0000000028995055 | ||
996 | ‡2 PTBNP|1782184 | ||
996 | ‡2 BLBNB|000574211 | ||
996 | ‡2 PTBNP|1452991 | ||
996 | ‡2 NKC|xx0236237 | ||
996 | ‡2 SUDOC|183435419 | ||
996 | ‡2 ISNI|0000000067122468 | ||
996 | ‡2 BNF|12340333 | ||
996 | ‡2 LC|no2021006415 | ||
996 | ‡2 PTBNP|213116 | ||
996 | ‡2 PTBNP|31122 | ||
996 | ‡2 ISNI|000000007069845X | ||
996 | ‡2 PTBNP|1374727 | ||
996 | ‡2 ISNI|0000000428240911 | ||
996 | ‡2 LC|n 2023253621 | ||
996 | ‡2 BLBNB|001478541 | ||
996 | ‡2 LC|no2021043106 | ||
996 | ‡2 NUKAT|n 2011221419 | ||
996 | ‡2 NUKAT|n 2010090060 | ||
996 | ‡2 PTBNP|204782 | ||
996 | ‡2 SUDOC|161602509 | ||
996 | ‡2 ISNI|0000000067986231 | ||
996 | ‡2 PTBNP|1289207 | ||
996 | ‡2 PTBNP|1868253 | ||
996 | ‡2 LC|n 2006218576 | ||
996 | ‡2 ISNI|0000000068511019 | ||
996 | ‡2 ISNI|0000000083896463 | ||
996 | ‡2 CAOONL|ncf11184479 | ||
996 | ‡2 LC|n 2020250614 | ||
996 | ‡2 PTBNP|224918 | ||
996 | ‡2 ISNI|0000000040808208 | ||
996 | ‡2 DNB|134231392 | ||
996 | ‡2 ISNI|0000000087987370 | ||
996 | ‡2 ISNI|0000000443368315 | ||
996 | ‡2 LC|n 85209938 | ||
996 | ‡2 PTBNP|1357610 | ||
996 | ‡2 PTBNP|250053 | ||
996 | ‡2 PTBNP|133981 | ||
996 | ‡2 LC|no2009158168 | ||
996 | ‡2 SUDOC|268579415 | ||
996 | ‡2 PTBNP|1273247 | ||
996 | ‡2 PTBNP|1862495 | ||
996 | ‡2 LC|n 79107219 | ||
996 | ‡2 BLBNB|001483422 | ||
996 | ‡2 ISNI|0000000077324821 | ||
996 | ‡2 PTBNP|1335093 | ||
996 | ‡2 ISNI|0000000079934682 | ||
996 | ‡2 LC|nr 91028243 | ||
996 | ‡2 SUDOC|145502058 | ||
996 | ‡2 ISNI|0000000069597117 | ||
996 | ‡2 DNB|1061005992 | ||
996 | ‡2 ISNI|000000007091583X | ||
996 | ‡2 BNE|XX5848470 | ||
996 | ‡2 BLBNB|001453922 | ||
996 | ‡2 PTBNP|1594628 | ||
996 | ‡2 NUKAT|n 2022001231 | ||
996 | ‡2 PTBNP|1143033 | ||
996 | ‡2 PTBNP|1494053 | ||
996 | ‡2 PTBNP|1536176 | ||
996 | ‡2 PTBNP|157382 | ||
996 | ‡2 PTBNP|283129 | ||
996 | ‡2 BNE|XX4894168 | ||
996 | ‡2 PTBNP|234642 | ||
996 | ‡2 SZ|1186735260 | ||
996 | ‡2 SUDOC|177887109 | ||
996 | ‡2 CAOONL|ncf11362390 | ||
996 | ‡2 PTBNP|1880867 | ||
996 | ‡2 PTBNP|1644395 | ||
996 | ‡2 PTBNP|51214 | ||
996 | ‡2 PTBNP|51216 | ||
996 | ‡2 BNF|15495759 | ||
996 | ‡2 BLBNB|000630343 | ||
996 | ‡2 BLBNB|000630344 | ||
996 | ‡2 ISNI|0000000387177302 | ||
996 | ‡2 RERO|A026828651 | ||
996 | ‡2 PTBNP|1439217 | ||
996 | ‡2 PTBNP|1418417 | ||
996 | ‡2 PTBNP|1667809 | ||
996 | ‡2 PTBNP|31076 | ||
996 | ‡2 LC|n 2023252896 | ||
996 | ‡2 ISNI|0000000072199689 | ||
996 | ‡2 PTBNP|1645277 | ||
996 | ‡2 PTBNP|1158266 | ||
996 | ‡2 PTBNP|1734267 | ||
996 | ‡2 SUDOC|258657669 | ||
996 | ‡2 ISNI|0000000067459458 | ||
996 | ‡2 BLBNB|000531231 | ||
996 | ‡2 SUDOC|280070799 | ||
996 | ‡2 ISNI|0000000026771971 | ||
996 | ‡2 BNF|14629557 | ||
996 | ‡2 ISNI|0000000370828439 | ||
996 | ‡2 BAV|495_57891 | ||
996 | ‡2 BLBNB|000363099 | ||
996 | ‡2 PTBNP|1042862 | ||
996 | ‡2 PTBNP|180084 | ||
996 | ‡2 BLBNB|001563910 | ||
996 | ‡2 PTBNP|1484942 | ||
996 | ‡2 BLBNB|001433091 | ||
996 | ‡2 PTBNP|36842 | ||
996 | ‡2 PLWABN|9814276084805606 | ||
996 | ‡2 SUDOC|273250264 | ||
996 | ‡2 LC|n 2007080761 | ||
996 | ‡2 DNB|1056419512 | ||
996 | ‡2 PTBNP|1897656 | ||
996 | ‡2 PTBNP|1268694 | ||
996 | ‡2 BLBNB|001510761 | ||
996 | ‡2 LC|no2011101629 | ||
996 | ‡2 LC|n 2024254111 | ||
996 | ‡2 DNB|1272699382 | ||
996 | ‡2 LC|n 91046158 | ||
996 | ‡2 PTBNP|1440402 | ||
996 | ‡2 SUDOC|076551393 | ||
996 | ‡2 PTBNP|1614464 | ||
996 | ‡2 PTBNP|1565064 | ||
996 | ‡2 ISNI|0000000070003486 | ||
996 | ‡2 BLBNB|001515289 | ||
996 | ‡2 DNB|118583558X | ||
996 | ‡2 PTBNP|1155466 | ||
996 | ‡2 DNB|115834886X | ||
996 | ‡2 ISNI|0000000041488066 | ||
996 | ‡2 ISNI|000000004080459X | ||
996 | ‡2 BLBNB|000540405 | ||
996 | ‡2 BLBNB|000527579 | ||
996 | ‡2 PTBNP|1813845 | ||
996 | ‡2 BLBNB|000281609 | ||
996 | ‡2 BNE|XX5485765 | ||
996 | ‡2 LC|n 2020250770 | ||
996 | ‡2 LC|n 2024254230 | ||
996 | ‡2 BLBNB|000427988 | ||
996 | ‡2 BLBNB|000431546 | ||
996 | ‡2 BLBNB|000163580 | ||
996 | ‡2 PTBNP|133055 | ||
996 | ‡2 ISNI|0000000029763010 | ||
996 | ‡2 ISNI|0000000401538064 | ||
996 | ‡2 BNE|XX5606955 | ||
996 | ‡2 CAOONL|ncf12046900 | ||
996 | ‡2 PTBNP|1424805 | ||
996 | ‡2 BLBNB|001463052 | ||
996 | ‡2 PTBNP|1276400 | ||
996 | ‡2 DNB|142297593 | ||
996 | ‡2 DNB|1226707904 | ||
996 | ‡2 PTBNP|1243375 | ||
996 | ‡2 ISNI|0000000033316627 | ||
996 | ‡2 NTA|403846609 | ||
996 | ‡2 ISNI|0000000118315797 | ||
996 | ‡2 PTBNP|1554688 | ||
996 | ‡2 PTBNP|1709750 | ||
996 | ‡2 ISNI|0000000068719901 | ||
996 | ‡2 ISNI|0000000069619419 | ||
996 | ‡2 ISNI|0000000080307264 | ||
996 | ‡2 BLBNB|000630147 | ||
996 | ‡2 PTBNP|169925 | ||
996 | ‡2 ISNI|0000000041751418 | ||
996 | ‡2 ISNI|000000007043194X | ||
996 | ‡2 ISNI|0000000068489341 | ||
996 | ‡2 LC|n 79098667 | ||
996 | ‡2 PTBNP|1472403 | ||
996 | ‡2 ISNI|0000000083276643 | ||
996 | ‡2 PTBNP|1197102 | ||
996 | ‡2 DNB|1057288446 | ||
996 | ‡2 PLWABN|9811302460505606 | ||
996 | ‡2 PTBNP|1174881 | ||
996 | ‡2 BLBNB|001014205 | ||
996 | ‡2 BLBNB|001484892 | ||
996 | ‡2 PTBNP|146489 | ||
996 | ‡2 ISNI|0000000112178664 | ||
996 | ‡2 PTBNP|1023665 | ||
996 | ‡2 ISNI|000000007022641X | ||
996 | ‡2 ISNI|0000000068415828 | ||
996 | ‡2 ISNI|0000000118396785 | ||
996 | ‡2 PTBNP|1252804 | ||
996 | ‡2 PTBNP|1469786 | ||
996 | ‡2 PTBNP|1774956 | ||
996 | ‡2 PTBNP|1741876 | ||
996 | ‡2 BLBNB|000166492 | ||
996 | ‡2 ISNI|0000000044028508 | ||
996 | ‡2 PTBNP|1673742 | ||
996 | ‡2 LC|n 2015247560 | ||
996 | ‡2 ISNI|0000000070833893 | ||
996 | ‡2 LC|n 2002012474 | ||
996 | ‡2 PTBNP|120477 | ||
996 | ‡2 BLBNB|000226939 | ||
996 | ‡2 PTBNP|1430356 | ||
996 | ‡2 ISNI|0000000070300798 | ||
996 | ‡2 BLBNB|000630628 | ||
996 | ‡2 ISNI|0000000105960906 | ||
996 | ‡2 LC|no2014035041 | ||
996 | ‡2 PTBNP|1841482 | ||
996 | ‡2 PTBNP|1224452 | ||
996 | ‡2 LC|n 2024253180 | ||
996 | ‡2 ISNI|0000000077948925 | ||
996 | ‡2 SUDOC|235152242 | ||
996 | ‡2 ISNI|000000007986387X | ||
996 | ‡2 PTBNP|918036 | ||
996 | ‡2 ISNI|0000000448676712 | ||
996 | ‡2 LC|n 2024182647 | ||
996 | ‡2 SUDOC|027209636 | ||
996 | ‡2 BLBNB|000336569 | ||
996 | ‡2 PTBNP|265426 | ||
996 | ‡2 PTBNP|1787325 | ||
996 | ‡2 DNB|1131738284 | ||
996 | ‡2 BNC|981058527931706706 | ||
996 | ‡2 ISNI|0000000069826848 | ||
996 | ‡2 BLBNB|000488880 | ||
996 | ‡2 PTBNP|118456 | ||
996 | ‡2 PTBNP|1412069 | ||
996 | ‡2 BLBNB|001558105 | ||
996 | ‡2 ISNI|0000000068589246 | ||
996 | ‡2 PTBNP|36639 | ||
996 | ‡2 DNB|1056533765 | ||
996 | ‡2 PTBNP|1700894 | ||
996 | ‡2 PTBNP|36636 | ||
996 | ‡2 PTBNP|36637 | ||
996 | ‡2 SUDOC|077752740 | ||
996 | ‡2 LC|no2023087735 | ||
996 | ‡2 PTBNP|1275253 | ||
996 | ‡2 LC|n 2008216058 | ||
996 | ‡2 ISNI|0000000069919147 | ||
996 | ‡2 PTBNP|1006639 | ||
996 | ‡2 BLBNB|001515007 | ||
996 | ‡2 ISNI|0000000045191083 | ||
996 | ‡2 PTBNP|143281 | ||
996 | ‡2 PTBNP|195132 | ||
996 | ‡2 PTBNP|1306272 | ||
996 | ‡2 RERO|A016335271 | ||
996 | ‡2 DNB|1183772068 | ||
996 | ‡2 ISNI|0000000078090502 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |